APA (7th ed.) Citation

TR, R., VS, T., G, T., CJ, H., AK, O., F, Z., & S, J. (2014). Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma. Immunologic research, 59(1-3), 188. https://doi.org/10.1007/s12026-014-8528-x

Chicago Style (17th ed.) Citation

TR, Rosean, Tompkins VS, Tricot G, Holman CJ, Olivier AK, Zhan F, and Janz S. "Preclinical Validation of Interleukin 6 as a Therapeutic Target in Multiple Myeloma." Immunologic Research 59, no. 1-3 (2014): 188. https://doi.org/10.1007/s12026-014-8528-x.

MLA (9th ed.) Citation

TR, Rosean, et al. "Preclinical Validation of Interleukin 6 as a Therapeutic Target in Multiple Myeloma." Immunologic Research, vol. 59, no. 1-3, 2014, p. 188, https://doi.org/10.1007/s12026-014-8528-x.